These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38141263)

  • 1. Is contrast-enhanced mammography (CEM) an alternative to MRI in assessing the response to primary systemic therapy of breast cancer?
    Sunen I; Isabel Garcia Barrado A; Cruz Ciria S; Garcia Maroto J; Gros Bañeres B; Garcia Mur C
    Eur J Radiol; 2024 Jan; 170():111270. PubMed ID: 38141263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging.
    Iotti V; Ravaioli S; Vacondio R; Coriani C; Caffarri S; Sghedoni R; Nitrosi A; Ragazzi M; Gasparini E; Masini C; Bisagni G; Falco G; Ferrari G; Braglia L; Del Prato A; Malavolti I; Ginocchi V; Pattacini P
    Breast Cancer Res; 2017 Sep; 19(1):106. PubMed ID: 28893303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-Enhanced Mammography Versus MRI in the Evaluation of Neoadjuvant Therapy Response in Patients With Breast Cancer: A Prospective Study.
    Bernardi D; Vatteroni G; Acquaviva A; Valentini M; Sabatino V; Bolengo I; Pellegrini M; Fantò C; Trimboli RM
    AJR Am J Roentgenol; 2022 Dec; 219(6):884-894. PubMed ID: 35731101
    [No Abstract]   [Full Text] [Related]  

  • 4. Contrast-Enhanced Mammography (CEM) for Detecting Residual Disease after Neoadjuvant Chemotherapy: A Comparison with Breast Magnetic Resonance Imaging (MRI).
    Barra FR; Sobrinho AB; Barra RR; Magalhães MT; Aguiar LR; de Albuquerque GFL; Costa RP; Farage L; Pratesi R
    Biomed Res Int; 2018; 2018():8531916. PubMed ID: 30533440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced mammography in the assessment of residual disease after neoadjuvant treatment.
    Hogan MP; Horvat JV; Ross DS; Sevilimedu V; Jochelson MS; Kirstein LJ; Goldfarb SB; Comstock CE; Sung JS
    Breast Cancer Res Treat; 2023 Apr; 198(2):349-359. PubMed ID: 36754936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy and precision of contrast enhanced mammography versus MRI for predicting breast cancer size: how "good" are they really?
    Taylor DB; Burrows S; Dessauvagie BF; Saunders CM; Ives A
    Br J Radiol; 2023 Mar; 96(1144):20211172. PubMed ID: 36753450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic contrast-enhanced mammography and breast MRI in the diagnosis of breast cancer and detection of tumor size.
    Tekinhatun M; Sabir N; Erdem E; Yilmaz S; Ufuk F
    Turk J Med Sci; 2024; 54(1):249-261. PubMed ID: 38812642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Performance of MRI, Molecular Breast Imaging, and Contrast-enhanced Mammography in Women with Newly Diagnosed Breast Cancer.
    Sumkin JH; Berg WA; Carter GJ; Bandos AI; Chough DM; Ganott MA; Hakim CM; Kelly AE; Zuley ML; Houshmand G; Anello MI; Gur D
    Radiology; 2019 Dec; 293(3):531-540. PubMed ID: 31660801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of Posttreatment Imaging for Evaluation of Residual in Breast Disease After Neoadjuvant Endocrine Therapy.
    Zhang C; Kosiorek HE; Patel BK; Pockaj BA; Ahmad SB; Cronin PA
    Ann Surg Oncol; 2022 Oct; 29(10):6207-6212. PubMed ID: 35831526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-Dose, Contrast-Enhanced Mammography Compared to Contrast-Enhanced Breast MRI: A Feasibility Study.
    Clauser P; Baltzer PAT; Kapetas P; Hoernig M; Weber M; Leone F; Bernathova M; Helbich TH
    J Magn Reson Imaging; 2020 Aug; 52(2):589-595. PubMed ID: 32061002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of contrast-enhanced mammography in the preoperative evaluation of invasive lobular carcinoma of the breast.
    Giannotti E; Van Nijnatten TJA; Chen Y; Bicchierai G; Nori J; De Benedetto D; Lalji U; Lee AHS; James J
    Clin Radiol; 2024 Jun; 79(6):e799-e806. PubMed ID: 38383254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Performance in Diagnosis and Characterization of Breast Lesions: Contrast-Enhanced Mammography Versus Breast Magnetic Resonance Imaging.
    Açar ÇR; Orguc S
    Clin Breast Cancer; 2024 Aug; 24(6):481-493. PubMed ID: 38777678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient perspectives on repeated contrast-enhanced mammography and magnetic resonance during neoadjuvant chemotherapy of breast cancer.
    Pires-Gonçalves L; Henriques Abreu M; Ferrão A; Guimarães Dos Santos A; Aguiar AT; Gouvêa M; Henrique R
    Acta Radiol; 2023 May; 64(5):1816-1822. PubMed ID: 36575580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CEM immediately after contrast-enhanced CT: a one-step staging of breast cancer.
    Ancona A; Telegrafo M; Fella RR; Iamele D; Cantore S; Moschetta M
    Eur Radiol Exp; 2024 Apr; 8(1):32. PubMed ID: 38556593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locoregional staging of breast cancer: contrast-enhanced mammography versus breast magnetic resonance imaging.
    Terzoni A; Basile P; Gambaro AC; Attanasio S; Rampi AM; Brambilla M; Carriero A
    Radiol Med; 2024 Apr; 129(4):558-565. PubMed ID: 38512618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-Enhanced Mammography (CEM) compared to Breast Magnetic Resonance (MRI) in the evaluation of breast lobular neoplasia.
    Nicosia L; Rotili A; Pesapane F; Bozzini AC; Battaglia O; Pellegrino G; Fusco N; Porta FM; Frassoni S; Bagnardi V; Corso G; Sangalli C; Cassano E
    Breast Cancer Res Treat; 2024 Jan; 203(1):135-143. PubMed ID: 37787819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PROCEM study protocol: Added value of preoperative contrast-enhanced mammography in staging of malignant breast lesions - a prospective randomized multicenter study.
    Åhsberg K; Gardfjell A; Nimeus E; Ryden L; Zackrisson S
    BMC Cancer; 2021 Oct; 21(1):1115. PubMed ID: 34663236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The performance of contrast-enhanced mammography and breast MRI in local preoperative staging of invasive lobular breast cancer.
    Lobbes MBI; Neeter LMFH; Raat F; Turk K; Wildberger JE; van Nijnatten TJA; Nelemans PJ
    Eur J Radiol; 2023 Jul; 164():110881. PubMed ID: 37201248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced mammography (CEM) versus MRI for breast cancer staging: detection of additional malignant lesions not seen on conventional imaging.
    Taylor DB; Burrows S; Saunders CM; Parizel PM; Ives A
    Eur Radiol Exp; 2023 Feb; 7(1):8. PubMed ID: 36781808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging findings for response evaluation of ductal carcinoma in situ in breast cancer patients treated with neoadjuvant systemic therapy: a systematic review and meta-analysis.
    Ploumen RAW; de Mooij CM; Gommers S; Keymeulen KBMI; Smidt ML; van Nijnatten TJA
    Eur Radiol; 2023 Aug; 33(8):5423-5435. PubMed ID: 37020070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.